We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

EKF Diagnostics

Manufactures analysers for the measurement of glucose, lactate, hemoglobin, hematocrit and HbA1c for GP surgeries, ph... read more Featured Products: More products

Download Mobile App





Quantitative Test for ß-Hydroxybutyrate Assesses Diabetic Ketoacidosis

By LabMedica International staff writers
Posted on 29 Jul 2013
Print article
A new quantitative strip-based test for ß-Hydroxybutyrate (ß-HB) provides a quick and easy assessment of diabetic ketoacidosis (DKA), delivering results in less than 80 seconds. The test has received the CE marking.

EKF Diagnostics' (Cardiff, United Kingdom) STAT-Site M ß-HB will be launched at the American Association for Clinical Chemistry’s Annual Meeting and Clinical Lab Expo (AACC 2013) in Houston, (TX, USA) from July 30 to August 1, 2013.

The presence and degree of ketosis can be rapidly assessed at the point-of-care (POC) by accurately measuring blood levels of ß-HB, which accounts for 78% of the three ketone bodies, from just 10 µL of serum or plasma. The information gained will guide quality care when monitoring DKA in newly diagnosed patients. It also reduces time and costs in an intensive care unit setting.

Also at AACC, highlighting the clinical utility of ß-HB for the screening and diagnosis of ketosis, the AACC Industry Workshop ‘Metabolic Disturbances That Lead to ß-Hydroxybutyrate and Ketone Bodies’ will be hosted by EKF on Tuesday July 30, 7–8 am.

This will be presented by POC specialist Dr. James Nichols, professor of pathology, microbiology & immunology and medical director of clinical chemistry at Vanderbilt University School of Medicine (Nashville, TN, USA). Attendees will learn about the critical inter-relationships of glucose, diabetes mellitus, and conditions that lead to DKA.

Other very recently launched EKF products will be demonstrated. These include another strip-based test for the rapid POC analysis of hemoglobin for anemia determination, STAT-Site M Hgb. This hand-held analyzer combines low cost per test with portability and reliably delivers accurate hemoglobin results within 30 seconds from 15 µL of finger-prick whole blood.

AACC delegates will also have the opportunity to meet the new EKF Molecular Diagnostics’ team and view research use only products for cancer gene-mutation enrichment and companion diagnostic applications.

These include newly introduced PointMan DNA enrichment kits which comprise three kits for enriching mutations in BRAF, KRAS and EGFR T790M genes associated with melanoma (skin cancer), colorectal, and lung cancers. PointMan kits offer highly specific and ultrasensitive enrichment of mutant genes in a background of wild-type (normal) genes.

Julian Baines, Group CEO, commented, “This year’s AACC Clinical Lab Expo is the first time we have showcased our new EKF Molecular Diagnostics cancer gene detection technology portfolio alongside our clinical chemistry and near-patient testing products. Our experts will be on hand to discuss our ever-broadening range of innovative and high-quality IVD diagnostics products. These are designed to rapidly and accurately detect and manage diabetes, anemia, lactate and kidney related diseases, as well as support better informed decisions on patient treatments through companion diagnostics.”

Related Links:
EKF Diagnostics
Vanderbilt University School of Medicine

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Total Thyroxine Assay
Total Thyroxine CLIA Kit
New
Creatine Kinase-MB Assay
CK-MB Test

Print article

Channels

Clinical Chemistry

view channel
Image: Professor Nicole Strittmatter (left) and first author Wei Chen stand in front of the mass spectrometer with a tissue sample (Photo courtesy of Robert Reich/TUM)

Mass Spectrometry Detects Bacteria Without Time-Consuming Isolation and Multiplication

Speed and accuracy are essential when diagnosing diseases. Traditionally, diagnosing bacterial infections involves the labor-intensive process of isolating pathogens and cultivating bacterial cultures,... Read more

Molecular Diagnostics

view channel
Image: Health Canada has approved SPINEstat, a first-in-class diagnostic blood test for axSpA, as a Class II medical device (Photo courtesy of Augurex)

First-in-Class Diagnostic Blood Test Detects Axial Spondyloarthritis

Axial spondyloarthritis (axSpA) is a chronic inflammatory autoimmune condition that typically affects individuals during their most productive years, with symptoms often emerging before the age of 45.... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.